Reference:

Keyword:
Issue date:
From:
To:
Originator: (For multiple select: Ctrl key + Click)



Reference Alert Title Originated ByIssue DateStatus
SDA/2021/002(U) Propofol emulsion for infusion and injection (all strengths) - Supply Disruption Update DHSC & NHS England and Improvement: Supply disruption alert 13-Apr-2021 Issued
CEM/CMO/2021/011 COVID-19 Therapeutic Alert - Inhaled Budesonide for Adults (50 Years and Over) with COVID-19 CMO Messaging 12-Apr-2021 Issued
CEM/CMO/2021/010 Convalescent Plasma in the Management of Hospitalised Patients with COVID-19 CMO Messaging 17-Mar-2021 Issued
CEM/CMO/2021/009 Updated information for clinicians/health care professionals on Covid-19 PCR testing CMO Messaging 12-Mar-2021 Issued
NatPSA/2021/001/MHRA Supply disruptions of sterile infusion sets and connectors manufactured by Becton Dickinson (BD) National Patient Safety Alert - MHRA 11-Mar-2021 Issued
SDA/2021/005 Repaglinide 1mg and 2mg tablets - Supply Disruption DHSC & NHS England and Improvement: Supply disruption alert 04-Mar-2021 Issued
CH/2021/002 Changes to MHRA Drug Alert titles and classifications CAS - Helpdesk - Team 04-Mar-2021 Issued
SDA/2021/004 Discontinuation of Morphine sulphate (MST CONTINUS) 20mg, 30mg, 60mg, 100mg and 200mg prolonged rele ... DHSC & NHS England and Improvement: Supply disruption alert 26-Feb-2021 Issued
CEM/CMO/2021/008 Fang Tian FT-045A FFP3 masks RECALL - Immediate Action Required CMO Messaging 24-Feb-2021 Issued
CEM/CMO/2021/007 Fang Tian FT-045A FFP3 masks - Immediate Action Required CMO Messaging 18-Feb-2021 Issued
12345678910...


* Alerts highlighted in blue are National Patient Safety Alerts. Further information about this type of alert can be found in this update.

Contact our helpdesk

Email: safetyalerts@mhra.gov.uk

Medicines and Healthcare products Regulatory Agency